Cytogen, DuPont Merck Pharmaceutical Co. regulatory update

The FDA filed an NDA submitted on June 12 by CYTO (Princeton, N.J.) and partner DuPont Merck for use of CYTO's Quadramet to treat severe and chronic pain associated with cancer that spreads to the bo...